Tag: Diabetes
Sequel Med Tech collaborates with Abbott
March 19, 2025HME News Staff
MANCHESTER, N.H. – Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery (AID) System powered by Tidepool. The sensor will be compatible with twiist when the system is expected to launch in the second quarter of 2025. “We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology as our first CGM partner,...
Strive Medical builds out diabetes biz
March 5, 2025HME News Staff
IRVING, Texas – Strive Medical, a portfolio company of NMS Capital, has acquired Charles Pharmacy & Surgical, a pharmacy and provider of diabetes supplies since 1968.
This strategic acquisition represents a major milestone in Strive Medical's continuous growth and dedication to delivering top-quality medical supplies and services to patients throughout the United States, the company says.
"We are thrilled to welcome Charles Pharmacy into the Strive Medical community,"...
In brief: Owens & Minor explores P&HS sale, Grassley challenges UHC, CCS details burnout
February 28, 2025HME News Staff
RICHMOND, Va.– Owens & Minor is looking to sell off its Products & Healthcare Services business, while it remains “bullish” on its Patient Direct business.
The company made the announcement today, as part of its fourth quarter and full-year 2024 earnings results.
“Our commitment to directing capital toward the higher growth and higher margin Patient Direct segment has been increasingly evident in recent years and is consistent with our strategy,” said...
AdaptHealth: Diabetes course correct shows ‘promising signs’
February 26, 2025Theresa Flaherty, Managing Editor
PLYMOUTH MEETING, Pa. – After consecutive declining quarters in Diabetes Health, AdaptHealth has remodeled its diabetes outreach program and integrated diabetes resupply into sleep resupply and adopted that segment's best practices, says CEO Suzanne Foster.
A diagnostic review highlighted several reasons for Diabetes Health’s underperformance, she told analysts on a recent call to discuss the company’s fourth quarter and full year 2024 financial results.
“Notwithstanding...
CCS study: Physicians ‘overwhelmed’ by soaring diabetes numbers
February 26, 2025HME News Staff
DALLAS – The vast majority of physicians caring for people with diabetes say they are overwhelmed, according to a new study from CCS, a provider of clinical solutions and home medical supplies for those living with chronic conditions.
Eighty-five percent of endocrinologists and 58% of PCPs feel overwhelmed by the number of patients with diabetes, demonstrating that many are not in a position to properly support the ongoing education and coaching needs of people living with diabetes,...
Spending on diabetes drugs skyrockets, gov’t says
February 25, 2025HME News Staff
WASHINGTON – Medicare Part D spending for 10 selected diabetes drugs totaled more than $35.8 billion in 2023, a 364% increase from 2019, according to a new data brief from the Department of Health and Human Services Office of Inspector General.
Meanwhile, the number of Medicare Part D enrollees increased from 44.9 million to 50.5 million, a 12% increase.
“Certain diabetes drugs initially approved by the Food and Drug Administration to help control blood sugar levels...
CGM bill aims to preserve two-channel option
February 14, 2025Theresa Flaherty, Managing Editor
LITTLE ROCK, Ark. – A new bill in Arkansas is the first on a state level to try and stem the “migration” of coverage for continuous glucose monitors to a pharmacy-only benefit.
Introduced Jan. 27, HB1255 would amend existing Medicaid coverage of CGMs to allow beneficiaries to obtain CGMs through the DME benefit and would allow DME providers to bill for the devices using a HCPCS code rather than the national drug code number used by pharmacies.
“We don't...
Senseonics files for CE Mark
February 13, 2025HME News Staff
GERMANTOWN, Md. – Senseonics Holdings has filed for CE Mark registration for the Eversense 365 CGM system, paving the way for commercialization in European Union countries by Acensia Diabetes Care. “Completing the CE Mark submission for Eversense 365 brings us a step closer to improving lives and health outcomes for patients in Europe,” said Tim Goodnow, president and CEO of Senseonics. “Given the success we have had to date with the U.S. launch, we look forward to the opportunity...
Byram Healthcare launches digital health program
February 11, 2025HME News Staff
RICHMOND, Va. – Byram Healthcare, part of the Owens & Minor family, has launched ByramConnect, a personalized digital health program for people with Type 1 and Type 2 diabetes that’s powered by the Welldoc app.
The program, using the Welldoc app’s artificial intelligence capabilities, analyzes member data across six dimensions of health to help optimize outcomes, providing actionable insights and reports that can be shared with providers and care teams.
“Chronic...
In brief: Trump turnaround, Homecare Champion finalists, TrueAire recall
February 7, 2025HME News Staff
WASHINGTON - President Donald Trump on Feb. 3 suspended his plans to implement 25% tariffs on products from Mexico and Canada, agreeing to a one-month pause in exchange for concessions on border security and crime enforcement.
The DME industry is closely monitoring the situation to see what, if any, exclusions might be included for medical equipment and products, according to a bulletin from VGM Government Relations.
An increase in tariffs, VGM says, could lead to several...